Revvity, Inc. (NYSE:RVTY) Shares Purchased by Toronto Dominion Bank

Toronto Dominion Bank grew its holdings in Revvity, Inc. (NYSE:RVTY - Free Report) by 40.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 58,374 shares of the company's stock after purchasing an additional 16,881 shares during the quarter. Toronto Dominion Bank's holdings in Revvity were worth $6,515,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. T. Rowe Price Investment Management Inc. grew its position in shares of Revvity by 16.7% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 20,761,308 shares of the company's stock worth $2,317,170,000 after buying an additional 2,969,326 shares during the last quarter. Vanguard Group Inc. grew its position in Revvity by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 14,290,211 shares of the company's stock worth $1,594,930,000 after purchasing an additional 156,679 shares during the last quarter. Price T Rowe Associates Inc. MD grew its position in Revvity by 17.8% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 7,631,597 shares of the company's stock worth $851,764,000 after purchasing an additional 1,151,821 shares during the last quarter. Janus Henderson Group PLC boosted its holdings in shares of Revvity by 0.4% in the 4th quarter. Janus Henderson Group PLC now owns 6,358,952 shares of the company's stock valued at $709,725,000 after acquiring an additional 23,650 shares during the last quarter. Finally, EdgePoint Investment Group Inc. boosted its holdings in shares of Revvity by 51.1% in the 4th quarter. EdgePoint Investment Group Inc. now owns 4,058,231 shares of the company's stock valued at $452,939,000 after acquiring an additional 1,372,456 shares during the last quarter. Institutional investors own 86.65% of the company's stock.

Analysts Set New Price Targets

RVTY has been the topic of several recent research reports. Robert W. Baird dropped their price objective on shares of Revvity from $127.00 to $125.00 and set an "outperform" rating on the stock in a report on Tuesday, April 29th. KeyCorp increased their price target on shares of Revvity from $132.00 to $145.00 and gave the stock an "overweight" rating in a report on Monday, February 3rd. Wells Fargo & Company lowered their price target on shares of Revvity from $130.00 to $102.00 and set an "equal weight" rating on the stock in a report on Thursday, April 17th. The Goldman Sachs Group lowered their price target on shares of Revvity from $140.00 to $125.00 and set a "buy" rating on the stock in a report on Tuesday, April 29th. Finally, Barclays reduced their price objective on shares of Revvity from $140.00 to $110.00 and set an "overweight" rating for the company in a research report on Thursday, April 10th. Five analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $125.64.

Revvity Price Performance

Shares of NYSE RVTY traded up $2.23 during mid-day trading on Tuesday, reaching $91.56. The company's stock had a trading volume of 314,485 shares, compared to its average volume of 949,147. The stock has a 50-day moving average of $96.30 and a two-hundred day moving average of $108.88. The stock has a market capitalization of $10.79 billion, a P/E ratio of 41.30, a P/E/G ratio of 3.82 and a beta of 1.02. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.03 and a current ratio of 3.60. Revvity, Inc. has a 1-year low of $88.01 and a 1-year high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last issued its earnings results on Monday, April 28th. The company reported $1.01 EPS for the quarter, beating analysts' consensus estimates of $0.96 by $0.05. The business had revenue of $664.76 million during the quarter, compared to analysts' expectations of $662.30 million. Revvity had a net margin of 9.81% and a return on equity of 7.68%. The company's quarterly revenue was up 2.3% compared to the same quarter last year. During the same period in the prior year, the business earned $0.98 earnings per share. On average, equities research analysts anticipate that Revvity, Inc. will post 4.94 EPS for the current fiscal year.

Revvity Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, August 8th. Stockholders of record on Friday, July 18th will be given a $0.07 dividend. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.31%. The ex-dividend date of this dividend is Friday, July 18th. Revvity's dividend payout ratio (DPR) is 11.91%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.